Company: MDXG
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0001376339-25-000048
Chunk: 98

Company: MIMEDX GROUP, INC.
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 98
---
-------------------------------------------|:----|:--------------------------------|--------:|:--|:----|:--|--------:|:--|
| Gross Profit                               |     | $                               | 288,806 |   |     | $ | 266,843 |   |
| Amortization of acquired intangible assets |     |                                 |   2,997 |   |     |   |       — |   |
| Adjusted Gross Profit                      |     | $                               | 291,803 |   |     | $ | 266,843 |   |
| Net Sales                                  |     | $                               | 348,879 |   |     | $ | 321,477 |   |
| Adjusted Gross Margin                      |     |                                 |    83.6 | % |     |   |    83.0 | % |

#### Free Cash Flow
Free Cash Flow is calculated as GAAP Cash Flows from Operating Activities less Capital Expenditures, including Purchases of Equipment.

We use Free Cash Flow as a measure of our operational liquidity, specifically our ability to generate cash in excess of investments into our business.

The following table reconciles GAAP Cash Flows from Operating Activities to Free Cash Flow (amounts in thousands):

|                                                        |     | Year Ended December 31, |     |   |   2024 |     |   |   2023 |
|:-------------------------------------------------------|:----|:------------------------|:----|:--|-------:|:----|:--|-------:|
| Net cash flows provided by operating activities        |     |                         |     | $ | 66,198 |     | $ | 26,775 |
| Capital expenditures, including purchases of equipment |     |                         |     |   | -1,683 |     |   | -1,987 |
| Free Cash Flow                                         |     |                         |     | $ | 64,515 |     | $ | 24,788 |

### APPENDIX B
<div align='center'>AMENDMENT TO THE MIMEDX GROUP, INC. 2016 EQUITY AND CASH INCENTIVE PLAN, AS AMENDED AND RESTATED</div>

WHEREAS , MiMedx Group, Inc., a Florida corporation (the “ Company ”) maintains the 2016 Equity and Cash Incentive Plan (as amended and restated, the “ Plan ”), the amendment and restatement of which was most recently adopted by the Company’s